Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · IEX Real-Time Price · USD
3.980
+0.010 (0.25%)
At close: Apr 18, 2024, 4:00 PM
3.900
-0.080 (-2.01%)
After-hours: Apr 18, 2024, 6:38 PM EDT

Aldeyra Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-37.54-62.02-57.78-37.55-60.83-38.89-22.34-18.7-12.09-9.57
Upgrade
Depreciation & Amortization
0.260.260.260.060.10.070.040.040.020
Upgrade
Share-Based Compensation
5.758.297.117.088.084.142.712.762.192.04
Upgrade
Other Operating Activities
1.2-3.167.85-7.087.664.820.370.760.57-1.63
Upgrade
Operating Cash Flow
-30.33-56.64-42.56-37.49-44.98-29.86-19.22-15.15-9.31-4.78
Upgrade
Capital Expenditures
0-0.02-0.010-0.01-0.26-0.02-0.01-0.09-0.01
Upgrade
Acquisitions
00000.6100000
Upgrade
Change in Investments
30-29.94029.0217.88-23.07-10.17-0.21-12.950
Upgrade
Investing Cash Flow
30-29.95-0.0129.0218.48-23.34-10.2-0.23-13.04-0.01
Upgrade
Share Issuance / Repurchase
0.311.22194.541.99.2581.9237.5912.7428.5110.06
Upgrade
Debt Issued / Paid
-1.0400014.45-1.40000
Upgrade
Other Financing Activities
-0.53----0.12--0.17--0.04-
Upgrade
Financing Cash Flow
-1.271.22194.541.923.5880.5337.4312.7428.4710.06
Upgrade
Net Cash Flow
-1.6-85.37151.9333.43-2.9327.338.01-2.636.125.26
Upgrade
Free Cash Flow
-30.33-56.65-42.56-37.49-44.99-30.12-19.25-15.16-9.4-4.79
Upgrade
Free Cash Flow Per Share
-0.51-0.97-0.79-1.10-1.66-1.39-1.21-1.33-1.09-1.25
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).